Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
Summary
- Studies in antiretroviral-naive and antiretroviral-experienced patients have generally demonstrated comparable response rates between men and women, although women are generally underrepresented among trial populations[Mocroft 2000; Moore 2003; Prins 2005; Collazos 2007; Hodder 2012; Mills 2009; Soon 2012; Patterson 2007]
- Recently, virologic efficacy of the fixed-dose combination cobicistat/elvitegravir/emtricitabine/tenofovir DF was shown to be superior to atazanavir/ritonavir plus emtricitabine/tenofovir DF in treatment-naive women[Squires 2016]
- Virologic efficacy of fixed-dose combination abacavir/dolutegravir/lamivudine also shown to be superior to atazanavir/ritonavir plus emtricitabine/tenofovir DF in treatment-naive women[Orrell 2017]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Initial Antiretroviral Therapy, Women